India’s pharmaceutical industry may be on the brink of a breakthrough in its export strategy, following a bold move by China. Beijing has announced a sweeping cut in import duties — slashing the 30 percent tariff on Indian pharmaceutical imports to zero. This decision is expected to open up a duty-free opportunity worth $10–15 billion for Indian drugmakers.










